|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBSCO_on1256237389 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
210612s2021 gw o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d N$T
|d OCLCF
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 3736964323
|
| 020 |
|
|
|a 9783736964327
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1256237389
|
| 050 |
|
4 |
|a SF959.S54
|
| 082 |
0 |
4 |
|a 636.108965
|2 23/eng/20220829
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Weber, Lisa Annabel.
|
| 245 |
1 |
0 |
|a In vitro and in vivo development of a topical drug for the treatment of equine skin cancer - based on naturally occurring and synthetically modified substances in plane bark
|h [electronic resource].
|
| 260 |
|
|
|a Göttingen :
|b Cuvillier Verlag,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (141 p.).
|
| 490 |
1 |
|
|a Wissenschaftliche Reihe der Klinik für Pferde ;
|v v.51
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a Intro -- LIST OF ABBREVIATIONS -- SUMMARY -- ZUSAMMENFASSUNG -- 1. Introduction -- 1.1. The equine malignant melanoma -- 1.2. The equine sarcoid: an overview -- 1.3. Topical drug application -- 1.4. Naturally occurring substances in plane bark and their syntheticallymodified derivatives -- 1.5. Hypotheses and aims of the thesis -- 2. Manuscript I:Betulinic acid shows anticancer activity against equine melanoma cells andpermeates isolated equine skin in vitro -- 2.1. Supplemental data
|
| 505 |
8 |
|
|a 3. Manuscript II:In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate asa topical treatment for equine skin cancer -- 4. Manuscript III:Concentration profiles and safety of topically applied betulinic acid andNVX-207 in eight healthy horses -- A randomized, blinded, placebocontrolled,crossover pilot study -- 5. Manuscript IV:Effects of topically applied betulinic acid and NVX-207 on early stageequine melanoma -- A prospective, randomized, double-blind, placebocontrolledpilot study -- 6. General discussion -- 6.1. Summarized findings -- 6.2. Interpretation of the findings
|
| 505 |
8 |
|
|a 7. Major findings and conclusions -- 8. Future perspectives -- 9. References -- Affidavit -- Acknowledgements
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Horses
|x Diseases.
|
| 650 |
|
0 |
|8 7\p
|a Skin
|x Cancer.
|
| 650 |
|
0 |
|8 8\p
|a Bark.
|
| 650 |
|
6 |
|a Chevaux
|x Maladies.
|
| 650 |
|
6 |
|a Peau
|x Cancer.
|
| 650 |
|
6 |
|a Écorce.
|
| 650 |
|
7 |
|a bark (plant material)
|2 aat
|
| 650 |
|
7 |
|a Bark
|2 fast
|
| 650 |
|
7 |
|a Horses
|x Diseases
|2 fast
|
| 650 |
|
7 |
|a Skin
|x Cancer
|2 fast
|
| 776 |
0 |
8 |
|i Print version:
|a Weber, Lisa Annabel
|t In vitro and in vivo development of a topical drug for the treatment of equine skin cancer - based on naturally occurring and synthetically modified substances in plane bark
|d Göttingen : Cuvillier Verlag,c2021
|z 9783736974326
|
| 830 |
|
0 |
|a Wissenschaftliche Reihe der Klinik für Pferde.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2942402
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6636881
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2942402
|
| 994 |
|
|
|a 92
|b IZTAP
|
